Alexion Pharmaceuticals, Inc. - Net Worth and Insider Trading
Alexion Pharmaceuticals, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alexion Pharmaceuticals, Inc. owns 1 companies in total, including Inozyme Pharma Inc (INZY) .
Click here to see the complete history of Alexion Pharmaceuticals, Inc.’s form 4 insider trades.
Insider Ownership Summary of Alexion Pharmaceuticals, Inc.
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
INZY | Inozyme Pharma Inc | 2020-07-23 | 10 percent owner |
Alexion Pharmaceuticals, Inc. Trading Performance
Alexion Pharmaceuticals, Inc. Ownership Network
Ownership Network List of Alexion Pharmaceuticals, Inc.
Ownership Network Relation of Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc. Owned Company Details
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Alexion Pharmaceuticals, Inc. is the 10 percent owner of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and See Remarks Henric Bjorn Bjarke .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Alexion Pharmaceuticals, Inc. made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net sale of 16,342 shares made by Douglas A Treco ,
In summary, during the past 3 months, insiders sold 8,819 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 8,819 shares. During the past 18 months, 16,342 shares of Inozyme Pharma Inc (INZY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 16,342 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
Alexion Pharmaceuticals, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Alexion Pharmaceuticals, Inc.. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Alexion Pharmaceuticals, Inc.'s mailing address is: Boston Ma 02210.